10-QPeriod: Q2 FY2011

UNITEDHEALTH GROUP INC Quarterly Report for Q2 Ended Jun 30, 2011

Filed August 2, 2011For Securities:UNH

Summary

UnitedHealth Group (UNH) reported solid financial results for the second quarter and first half of 2011, demonstrating continued revenue and earnings growth. Total revenues increased by 8% for the quarter and 9% for the first six months, driven by strong performance in both its Health Benefits (UnitedHealthcare) and Health Services (Optum) platforms. Net earnings saw a robust increase of 13% for the quarter and 13% for the first half, reflecting effective cost management and operational efficiencies. The company's balance sheet remains strong, with total assets growing to $66.1 billion. Key balance sheet items such as cash and cash equivalents and short-term investments saw significant increases, indicating healthy liquidity. The company also continued its commitment to shareholder returns through share repurchases and an increased dividend. Management highlighted continued growth across its various business segments, particularly in UnitedHealthcare's commercial and public/senior offerings, and across the Optum businesses which are benefiting from acquisitions and organic growth. Despite a complex regulatory environment, including the ongoing impacts of the Affordable Care Act, UNH demonstrated its ability to navigate challenges and deliver positive financial outcomes for investors.

Financial Highlights

51 data points
Beta

Revenue

$25.23B

97.8% Gross Margin

Net Income

$1.27B

5.0% Net Margin

EPS (Diluted)

$1.16

Total Assets

$66.11B

Cash & Equivalents

$9.78B

Free Cash Flow

$892.00M

Financial Statements
Beta
Revenue$25.23B
Cost of Revenue$554.00M
Gross Profit$24.68B
SG&A Expenses$3.73B
Operating Expenses$23.14B
Operating Income$2.10B
Interest Expense$119.00M
Net Income$1.27B
EPS (Basic)$1.18
EPS (Diluted)$1.16
Shares Outstanding (Basic)1.07B
Shares Outstanding (Diluted)1.09B

Key Highlights

  • 1Total revenues increased by 8% year-over-year to $25.2 billion for the quarter and 9% to $50.7 billion for the first six months, driven by growth in both UnitedHealthcare and Optum segments.
  • 2Net earnings grew by 13% to $1.3 billion ($1.16 per diluted share) for the quarter and 13% to $2.6 billion ($2.38 per diluted share) for the first six months.
  • 3Medical costs, while increasing, were managed effectively, with a stable medical care ratio of 81.4% for both periods.
  • 4Operating costs increased by 11% for the quarter and 9% for the first six months, largely due to business growth and acquisitions, but operating margins remained stable.
  • 5The company repurchased approximately 28 million shares for $1.3 billion in the first six months of 2011 and increased its quarterly dividend to $0.1625 per share.
  • 6Goodwill increased by $778 million to $23.4 billion, primarily due to acquisitions within the OptumHealth segment.
  • 7The company maintained a strong balance sheet with total assets of $66.1 billion and total liabilities of $38.8 billion as of June 30, 2011.

Frequently Asked Questions

Revenue growth was primarily driven by strong organic growth in risk-based offerings within the UnitedHealthcare businesses, as well as increased revenue across all Optum businesses, benefiting from acquisitions and expanded customer reach. Premium revenues increased by 8% and service revenues by 17% for the quarter.

Medical costs increased by 8% for the quarter, in line with revenue growth and membership increases. The company maintained a stable medical care ratio of 81.4% for both the three and six-month periods, indicating effective cost management despite rising healthcare utilization and costs. Favorable medical cost development from prior periods also contributed positively.

UnitedHealth Group demonstrated a commitment to returning capital to shareholders by repurchasing approximately 28 million shares of common stock for $1.3 billion in the first six months of 2011. Additionally, the company increased its quarterly cash dividend to $0.1625 per share, signaling confidence in its financial performance and future cash flows. The company also continued to invest in growth through acquisitions, as evidenced by the increase in goodwill.

The Health Reform Legislation continues to influence the company's operations. Key impacts include potential rebates on commercial health plans based on medical loss ratios, increased scrutiny on premium rate increases by state regulators, and changes to Medicare Advantage payment rates. The company is actively managing these impacts through pricing strategies, cost management, and by focusing on quality improvements to potentially earn bonuses.